Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Rubio

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Plos One|November 7, 2017
Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disordersNuria García-Marchena, Daniel Silva-Peña, Ana Isabel Martín-Velasco, et al.
Addiction Biology|May 24, 2016
Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinenceNuria Garcia-Marchena, Francisco J Pavon, Antoni Pastor, et al.
Brain Sciences|May 28, 2022
Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use DisordersMaría Flores-López, Nuria García-Marchena, Pedro Araos, et al.
Frontiers in Psychiatry|July 3, 2023
How, when, and to what degree do people with alcohol dependence recover their psychological wellbeing and quality of life? The Madrid Recovery ProjectGabriel Rubio, Laura Esteban Rodríguez, Ana Sion, et al.
Addiction Biology|October 3, 2018
Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and ratsDaniel Silva-Peña, Nuria García-Marchena, Francisco Alén, et al.
Journal of Psychopharmacology (Oxford, England)|June 16, 2020
Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseasesNuria García-Marchena, Rosa Maza-Quiroga, Antonia Serrano, et al.
Frontiers in Psychiatry|February 3, 2017
Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric ComorbidityNuria García-Marchena, Pedro Fernando Araos, Vicente Barrios, et al.
Biomedicines|September 28, 2021
Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver DiseaseMaría Flores-López, Nuria García-Marchena, Francisco Javier Pavon, et al.
Schizophrenia Bulletin|March 15, 2013
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophreniaBorja García-Bueno, Miquel Bioque, Karina S Mac-Dowell, et al.
Drug and Alcohol Dependence|September 21, 2025
Predictive performance for alcohol use disorder of polygenic scores based on the general addiction risk factor and problematic alcohol useAna M Pérez-Gutiérrez, Gerardo Flórez, Vanessa Blanco, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Plos One|November 7, 2017
Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disordersNuria García-Marchena, Daniel Silva-Peña, Ana Isabel Martín-Velasco, et al.
Addiction Biology|May 24, 2016
Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinenceNuria Garcia-Marchena, Francisco J Pavon, Antoni Pastor, et al.
Brain Sciences|May 28, 2022
Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use DisordersMaría Flores-López, Nuria García-Marchena, Pedro Araos, et al.
Frontiers in Psychiatry|July 3, 2023
How, when, and to what degree do people with alcohol dependence recover their psychological wellbeing and quality of life? The Madrid Recovery ProjectGabriel Rubio, Laura Esteban Rodríguez, Ana Sion, et al.
Addiction Biology|October 3, 2018
Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and ratsDaniel Silva-Peña, Nuria García-Marchena, Francisco Alén, et al.
Journal of Psychopharmacology (Oxford, England)|June 16, 2020
Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseasesNuria García-Marchena, Rosa Maza-Quiroga, Antonia Serrano, et al.
Frontiers in Psychiatry|February 3, 2017
Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric ComorbidityNuria García-Marchena, Pedro Fernando Araos, Vicente Barrios, et al.
Biomedicines|September 28, 2021
Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver DiseaseMaría Flores-López, Nuria García-Marchena, Francisco Javier Pavon, et al.
Schizophrenia Bulletin|March 15, 2013
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophreniaBorja García-Bueno, Miquel Bioque, Karina S Mac-Dowell, et al.
Drug and Alcohol Dependence|September 21, 2025
Predictive performance for alcohol use disorder of polygenic scores based on the general addiction risk factor and problematic alcohol useAna M Pérez-Gutiérrez, Gerardo Flórez, Vanessa Blanco, et al.
Pageof 16